28 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
Not
Disclose
Gender
Part I: Gender Identity
Directors
Part II: Demographic Background
African American or Black
Alaskan Native or Native American
Asian
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
for the Option Exchange were determined using the Black-Scholes model and are based on, among other things, $0.679, the per share closing trading
SC TO-I
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
of Aligos Therapeutics, Inc. common stock and have an aggregate value of $1,090,508.90 as of January 29, 2024, calculated using the Black-Scholes option
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
based on the exercise price and remaining term of the Eligible Option. The exchange ratios for the Option Exchange were determined using the Black … price of the Eligible Options The exchange ratios for the Option Exchange were determined using the Black-Scholes model and are based on, among other
8-K
EX-4.2
9yoj cqv9
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
424B4
yw2nu82w9qx965omwgo
1 Jul 21
Prospectus supplement with pricing info
4:31pm
DRS
3yrval
4 Jun 21
Draft registration statement
12:00am